Cargando…

Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study

Two recent phase 3 trials showed that outcomes for relapsed/refractory (R/R) FLT3-mutated acute myeloid leukemia (AML) patients may be improved by a single-agent tyrosine kinase inhibitor (TKI) (i.e., quizartinib or gilteritinib). In the current study, we retrospectively investigated the characteris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dumas, Pierre-Yves, Bertoli, Sarah, Bérard, Emilie, Largeaud, Laetitia, Bidet, Audrey, Delabesse, Eric, Leguay, Thibaut, Leroy, Harmony, Gadaud, Noémie, Rieu, Jean Baptiste, Vial, Jean-Philippe, Vergez, François, Lechevalier, Nicolas, Luquet, Isabelle, Klein, Emilie, Sarry, Audrey, de Grande, Anne-Charlotte, Pigneux, Arnaud, Récher, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465142/ https://www.ncbi.nlm.nih.gov/pubmed/32722211 http://dx.doi.org/10.3390/cancers12082044

Ejemplares similares

Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse–Bordeaux DATAML Registry Study
por: Bertoli, Sarah, et al.
Publicado: (2020)

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes
por: Galtier, Jean, et al.
Publicado: (2021)

Vitamin C and D supplementation in acute myeloid leukemia
por: Mouchel, Pierre Luc, et al.
Publicado: (2023)

CD34(+)CD38(−)CD123(+) Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents
por: Vergez, François, et al.
Publicado: (2020)

Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)

Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia
por: Vergez, François, et al.
Publicado: (2022)

Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia
por: Vial, Jean Philippe, et al.
Publicado: (2021)

Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience
por: Bertoli, Sarah, et al.
Publicado: (2019)

A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries
por: Bérard, Emilie, et al.
Publicado: (2022)

Improved outcome for AML patients over the years 2000–2014
por: Bertoli, Sarah, et al.
Publicado: (2017)

Dexamethasone in hyperleukocytic acute myeloid leukemia
por: Bertoli, Sarah, et al.
Publicado: (2018)

Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia
por: Dumas, Pierre-Yves, et al.
Publicado: (2017)

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia
por: Bertoli, Sarah, et al.
Publicado: (2015)

Acute myeloid leukemia with myelodysplasia-related changes and basophilic differentiation
por: Rieu, Jean-Baptiste, et al.
Publicado: (2020)

Do not jump to hasty conclusions: all gamma delta T-cells neoplasms are not aggressive!
por: Vergez, François, et al.
Publicado: (2019)

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine
por: Bories, Pierre, et al.
Publicado: (2020)

When dystrophic plasma cells do not recognize themselves in the mirror
por: Rieu, Jean‐Baptiste, et al.
Publicado: (2020)

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies
por: Bertoli, Sarah, et al.
Publicado: (2016)

Cost comparison of post-remission strategies in younger and older AML patients in France
por: Mounie, Michael, et al.
Publicado: (2023)

Unusual Transmission of Plasmodium falciparum, Bordeaux, France, 2009
por: Vareil, Marc-Olivier, et al.
Publicado: (2011)

A case of cup‐like blasts associated with B‐lymphoblastic leukemia without NPM1 and FLT3 internal tandem duplication mutations
por: Rieu, Jean‐Baptiste, et al.
Publicado: (2020)

Bristol and Bordeaux
por: Cosh, J. A.
Publicado: (1957)

The Bordeaux Conference
Publicado: (1924)

Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients
por: Berger, Eloïse, et al.
Publicado: (2019)

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience
por: LaRochelle, Olivier, et al.
Publicado: (2011)

Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells
por: Dupont, Marine, et al.
Publicado: (2022)

Toulouse-Lautre
por: Tietze, Hans
Publicado: (1949)

Toulouse-Lautrec /
por: Jane Avril
Publicado: (1965)

Aptamers in Bordeaux, 24–25 June 2016
por: Toulmé, Jean-Jacques, et al.
Publicado: (2017)

La Tauromaquia and the bulls of Bordeaux /
por: Goya y Lucientes, Francisco, 1746-1828
Publicado: (1969)

Bordeaux Method of Dressing Wounds
Publicado: (1877)

Somatic genetic alterations predict hematological progression in GATA2 deficiency
por: Largeaud, Laetitia, et al.
Publicado: (2023)

Prognostic impact of viral reactivations in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation in first complete response
por: Guenounou, Sarah, et al.
Publicado: (2016)

Toulouse : d'hier et d'aujourd'hui /
por: Cousteaux, Fernand
Publicado: (1985)

Toulouse-Lautrec : obra gráfica completa
por: Adriani, Götz 1940-
Publicado: (1981)

Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries
por: Récher, Christian, et al.
Publicado: (2021)

Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL
por: Dumas, Pierre-Yves, et al.
Publicado: (2019)

Henri de Toulouse-Lautrec
por: Toulouse-Lautrec, Henri de, 1864-1901
Publicado: (1978)

Le capitole de Toulouse /
por: Baudis, Dominique
Publicado: (1988)

Color Characterization of Bordeaux Red Wines Produced without Added Sulfites
por: Pelonnier-Magimel, Edouard, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b54d40fjjqnmr48julo5qgapki